Zydus Announced the Supplies of ZyCoV-D to Government of India

Zydus has started supplies of its Covid-19 vaccine to the government of India against the order from its newly commissioned state-of-the-art Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.

ZyCoV-D is a three-dose vaccine and is planning to make it available in the private market. It uses a painless PharmaJet needle-free system, Tropis, on day 0, day 28, and day 56. The manufacturing process and in-process material transfers within the plant are automated. 

The company has entered a definitive agreement with Shilpa Medicare. It has also entered an agreement with Enzychem Lifesciences of the Republic of Korea for the manufacturing license and technology transfer for the Plasmid DNA vaccine.